Longitudinal and quantitative MR plaque imaging for prediction of response to medical management in symptomatic intracranial atherosclerosis View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

2019-2024

FUNDING AMOUNT

1762727.0 USD

ABSTRACT

ABSTRACT Intracranial atherosclerotic disease (ICAD) is one of the most common causes of ischemic stroke worldwide. Despite intensive medical management, the current standard of care for secondary stroke prevention, the rate of recurrent stroke is 13% in the first year and as high as 35% in certain populations by 2 years. Currently, the initial and follow-up evaluations of these patients rely exclusively on assessments of clinical risk factors and, in some circumstances, the degree of luminal stenosis on imaging. However, this strategy may overlook subtle non-luminal changes within ICAD lesions. A tool that can directly probe atherosclerotic plaques and accurately quantify longitudinal changes of plaque features may help early identify non-responsive patients in whom an alternative therapy can be initiated. Magnetic resonance (MR) vessel wall imaging (VWI) has the potential to fulfill this role because of its compacity to directly visualize the vessel wall and characterize plaque features. However, there are several technical challenges associated with intracranial VWI: small size, tortuous course, and deep sitting warrant a high-resolution and 3D imaging approach; multiple lesion sites require a large imaging view; signals arising from neighboring blood and cerebrospinal fluid (CSF) need to be adequately suppressed; relatively long imaging time and potential image corruption by patient motion; and lack of dedicated plaque analysis tools particularly for 3D dataset. In this proposal, we will develop a reliable 3D VWI- based MR plaque imaging (MRPI) strategy for prediction of response to medical management in symptomatic ICAD. Specifically, we will first develop a whole-brain 3D VWI sequence with intracranial vessel-dedicated motion compensation and motion-adaptive imaging acceleration (Aim1-Task1) and develop an automated intracranial vessel wall (IVA) tool integrating 3D vessel wall segmentation and computational algorithms for deriving quantitative plaque features (Aim1-Task2) followed by a validation study (Aim1-Task3). The validated techniques will then be used in a cross-sectional study to determine the MRPI-derived quantitative plaque features that are associated with ICAD lesions within the infarcted territory in patients with acute symptomatic ICAD (Aim 2). We will finally conduct a longitudinal study to determine the capacity of longitudinal and quantitative MRPI to predict response to medical management in symptomatic ICAD patients (Aim 3). Successful completion of the project will validate the compacity of VWI-based MRPI to quantitatively characterize ICAD and predict response to medical management in symptomatic ICAD patients. This will open the door to future clinical trials investigating the role of MRPI in developing personalized management paradigms and assessing new therapies. More... »

URL

http://projectreporter.nih.gov/project_info_description.cfm?aid=10366094

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/40", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "amount": {
      "currency": "USD", 
      "type": "MonetaryAmount", 
      "value": 1762727.0
    }, 
    "description": "ABSTRACT Intracranial atherosclerotic disease (ICAD) is one of the most common causes of ischemic stroke worldwide. Despite intensive medical management, the current standard of care for secondary stroke prevention, the rate of recurrent stroke is 13% in the first year and as high as 35% in certain populations by 2 years. Currently, the initial and follow-up evaluations of these patients rely exclusively on assessments of clinical risk factors and, in some circumstances, the degree of luminal stenosis on imaging. However, this strategy may overlook subtle non-luminal changes within ICAD lesions. A tool that can directly probe atherosclerotic plaques and accurately quantify longitudinal changes of plaque features may help early identify non-responsive patients in whom an alternative therapy can be initiated. Magnetic resonance (MR) vessel wall imaging (VWI) has the potential to fulfill this role because of its compacity to directly visualize the vessel wall and characterize plaque features. However, there are several technical challenges associated with intracranial VWI: small size, tortuous course, and deep sitting warrant a high-resolution and 3D imaging approach; multiple lesion sites require a large imaging view; signals arising from neighboring blood and cerebrospinal fluid (CSF) need to be adequately suppressed; relatively long imaging time and potential image corruption by patient motion; and lack of dedicated plaque analysis tools particularly for 3D dataset. In this proposal, we will develop a reliable 3D VWI- based MR plaque imaging (MRPI) strategy for prediction of response to medical management in symptomatic ICAD. Specifically, we will first develop a whole-brain 3D VWI sequence with intracranial vessel-dedicated motion compensation and motion-adaptive imaging acceleration (Aim1-Task1) and develop an automated intracranial vessel wall (IVA) tool integrating 3D vessel wall segmentation and computational algorithms for deriving quantitative plaque features (Aim1-Task2) followed by a validation study (Aim1-Task3). The validated techniques will then be used in a cross-sectional study to determine the MRPI-derived quantitative plaque features that are associated with ICAD lesions within the infarcted territory in patients with acute symptomatic ICAD (Aim 2). We will finally conduct a longitudinal study to determine the capacity of longitudinal and quantitative MRPI to predict response to medical management in symptomatic ICAD patients (Aim 3). Successful completion of the project will validate the compacity of VWI-based MRPI to quantitatively characterize ICAD and predict response to medical management in symptomatic ICAD patients. This will open the door to future clinical trials investigating the role of MRPI in developing personalized management paradigms and assessing new therapies.", 
    "endDate": "2024-02-29", 
    "funder": {
      "id": "http://www.grid.ac/institutes/grid.279885.9", 
      "type": "Organization"
    }, 
    "id": "sg:grant.8388914", 
    "identifier": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "grant.8388914"
        ]
      }, 
      {
        "name": "nih_id", 
        "type": "PropertyValue", 
        "value": [
          "R01HL147355"
        ]
      }
    ], 
    "keywords": [
      "intracranial atherosclerotic disease", 
      "symptomatic intracranial atherosclerotic disease", 
      "vessel wall imaging", 
      "quantitative plaque features", 
      "symptomatic ICAD patients", 
      "medical management", 
      "plaque features", 
      "prediction of response", 
      "ICAD patients", 
      "cerebrospinal fluid", 
      "intensive medical management", 
      "secondary stroke prevention", 
      "clinical risk factors", 
      "symptomatic intracranial atherosclerosis", 
      "non-responsive patients", 
      "future clinical trials", 
      "cross-sectional study", 
      "magnetic resonance vessel wall imaging", 
      "MR plaque", 
      "recurrent stroke", 
      "stroke prevention", 
      "ischemic stroke", 
      "intracranial atherosclerosis", 
      "atherosclerotic disease", 
      "luminal stenosis", 
      "infarcted territory", 
      "risk factors", 
      "alternative therapies", 
      "clinical trials", 
      "common cause", 
      "new therapies", 
      "atherosclerotic plaques", 
      "lesion site", 
      "patients", 
      "multiple lesion sites", 
      "longitudinal changes", 
      "tortuous course", 
      "vessel wall", 
      "longitudinal study", 
      "certain populations", 
      "imaging strategies", 
      "current standard", 
      "therapy", 
      "lesions", 
      "stroke", 
      "plaques", 
      "imaging views", 
      "intracranial vessel wall imaging", 
      "first year", 
      "validation study", 
      "imaging approach", 
      "response", 
      "management", 
      "stenosis", 
      "wall imaging", 
      "atherosclerosis", 
      "years", 
      "disease", 
      "blood", 
      "patient motion", 
      "trials", 
      "care", 
      "prevention", 
      "study", 
      "MRPI", 
      "cause", 
      "successful completion", 
      "role", 
      "imaging", 
      "changes", 
      "population", 
      "warrants", 
      "course", 
      "assessment", 
      "completion", 
      "factors", 
      "features", 
      "strategies", 
      "evaluation", 
      "rate", 
      "lack", 
      "management paradigm", 
      "fluid", 
      "tool", 
      "wall", 
      "technical challenges", 
      "sites", 
      "standards", 
      "time", 
      "degree", 
      "potential", 
      "circumstances", 
      "challenges", 
      "capacity", 
      "small size", 
      "paradigm", 
      "door", 
      "size", 
      "technique", 
      "approach", 
      "territory", 
      "view", 
      "sequence", 
      "signals", 
      "prediction", 
      "wall segmentation", 
      "motion", 
      "compensation", 
      "acceleration", 
      "project", 
      "vessel wall segmentation", 
      "dataset", 
      "motion compensation", 
      "proposal", 
      "analysis tools", 
      "segmentation", 
      "compacity", 
      "computational algorithm", 
      "algorithm", 
      "image corruption", 
      "corruption"
    ], 
    "name": "Longitudinal and quantitative MR plaque imaging for prediction of response to medical management in symptomatic intracranial atherosclerosis", 
    "recipient": [
      {
        "id": "http://www.grid.ac/institutes/grid.42505.36", 
        "type": "Organization"
      }, 
      {
        "affiliation": {
          "id": "http://www.grid.ac/institutes/None", 
          "name": "UNIVERSITY OF SOUTHERN CALIFORNIA", 
          "type": "Organization"
        }, 
        "familyName": "FAN", 
        "givenName": "ZHAOYANG", 
        "id": "sg:person.01136172260.58", 
        "type": "Person"
      }, 
      {
        "member": "sg:person.01136172260.58", 
        "roleName": "PI", 
        "type": "Role"
      }
    ], 
    "sameAs": [
      "https://app.dimensions.ai/details/grant/grant.8388914"
    ], 
    "sdDataset": "grants", 
    "sdDatePublished": "2022-11-24T21:22", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/grant/grant_69.jsonl", 
    "startDate": "2019-03-15", 
    "type": "MonetaryGrant", 
    "url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=10366094"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.8388914'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.8388914'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.8388914'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.8388914'


 

This table displays all metadata directly associated to this object as RDF triples.

165 TRIPLES      18 PREDICATES      142 URIs      134 LITERALS      5 BLANK NODES

Subject Predicate Object
1 sg:grant.8388914 schema:about anzsrc-for:40
2 schema:amount N462e16d6c0034f27bd45116416685bae
3 schema:description ABSTRACT Intracranial atherosclerotic disease (ICAD) is one of the most common causes of ischemic stroke worldwide. Despite intensive medical management, the current standard of care for secondary stroke prevention, the rate of recurrent stroke is 13% in the first year and as high as 35% in certain populations by 2 years. Currently, the initial and follow-up evaluations of these patients rely exclusively on assessments of clinical risk factors and, in some circumstances, the degree of luminal stenosis on imaging. However, this strategy may overlook subtle non-luminal changes within ICAD lesions. A tool that can directly probe atherosclerotic plaques and accurately quantify longitudinal changes of plaque features may help early identify non-responsive patients in whom an alternative therapy can be initiated. Magnetic resonance (MR) vessel wall imaging (VWI) has the potential to fulfill this role because of its compacity to directly visualize the vessel wall and characterize plaque features. However, there are several technical challenges associated with intracranial VWI: small size, tortuous course, and deep sitting warrant a high-resolution and 3D imaging approach; multiple lesion sites require a large imaging view; signals arising from neighboring blood and cerebrospinal fluid (CSF) need to be adequately suppressed; relatively long imaging time and potential image corruption by patient motion; and lack of dedicated plaque analysis tools particularly for 3D dataset. In this proposal, we will develop a reliable 3D VWI- based MR plaque imaging (MRPI) strategy for prediction of response to medical management in symptomatic ICAD. Specifically, we will first develop a whole-brain 3D VWI sequence with intracranial vessel-dedicated motion compensation and motion-adaptive imaging acceleration (Aim1-Task1) and develop an automated intracranial vessel wall (IVA) tool integrating 3D vessel wall segmentation and computational algorithms for deriving quantitative plaque features (Aim1-Task2) followed by a validation study (Aim1-Task3). The validated techniques will then be used in a cross-sectional study to determine the MRPI-derived quantitative plaque features that are associated with ICAD lesions within the infarcted territory in patients with acute symptomatic ICAD (Aim 2). We will finally conduct a longitudinal study to determine the capacity of longitudinal and quantitative MRPI to predict response to medical management in symptomatic ICAD patients (Aim 3). Successful completion of the project will validate the compacity of VWI-based MRPI to quantitatively characterize ICAD and predict response to medical management in symptomatic ICAD patients. This will open the door to future clinical trials investigating the role of MRPI in developing personalized management paradigms and assessing new therapies.
4 schema:endDate 2024-02-29
5 schema:funder grid-institutes:grid.279885.9
6 schema:identifier N31ce99adc23f4abe8465eb0e95354704
7 N94f0c214f12f4a1a8babe4c87b6d4415
8 schema:keywords ICAD patients
9 MR plaque
10 MRPI
11 acceleration
12 algorithm
13 alternative therapies
14 analysis tools
15 approach
16 assessment
17 atherosclerosis
18 atherosclerotic disease
19 atherosclerotic plaques
20 blood
21 capacity
22 care
23 cause
24 cerebrospinal fluid
25 certain populations
26 challenges
27 changes
28 circumstances
29 clinical risk factors
30 clinical trials
31 common cause
32 compacity
33 compensation
34 completion
35 computational algorithm
36 corruption
37 course
38 cross-sectional study
39 current standard
40 dataset
41 degree
42 disease
43 door
44 evaluation
45 factors
46 features
47 first year
48 fluid
49 future clinical trials
50 image corruption
51 imaging
52 imaging approach
53 imaging strategies
54 imaging views
55 infarcted territory
56 intensive medical management
57 intracranial atherosclerosis
58 intracranial atherosclerotic disease
59 intracranial vessel wall imaging
60 ischemic stroke
61 lack
62 lesion site
63 lesions
64 longitudinal changes
65 longitudinal study
66 luminal stenosis
67 magnetic resonance vessel wall imaging
68 management
69 management paradigm
70 medical management
71 motion
72 motion compensation
73 multiple lesion sites
74 new therapies
75 non-responsive patients
76 paradigm
77 patient motion
78 patients
79 plaque features
80 plaques
81 population
82 potential
83 prediction
84 prediction of response
85 prevention
86 project
87 proposal
88 quantitative plaque features
89 rate
90 recurrent stroke
91 response
92 risk factors
93 role
94 secondary stroke prevention
95 segmentation
96 sequence
97 signals
98 sites
99 size
100 small size
101 standards
102 stenosis
103 strategies
104 stroke
105 stroke prevention
106 study
107 successful completion
108 symptomatic ICAD patients
109 symptomatic intracranial atherosclerosis
110 symptomatic intracranial atherosclerotic disease
111 technical challenges
112 technique
113 territory
114 therapy
115 time
116 tool
117 tortuous course
118 trials
119 validation study
120 vessel wall
121 vessel wall imaging
122 vessel wall segmentation
123 view
124 wall
125 wall imaging
126 wall segmentation
127 warrants
128 years
129 schema:name Longitudinal and quantitative MR plaque imaging for prediction of response to medical management in symptomatic intracranial atherosclerosis
130 schema:recipient Ndbc359a766b948d6881faee678ac3dfc
131 sg:person.01136172260.58
132 grid-institutes:grid.42505.36
133 schema:sameAs https://app.dimensions.ai/details/grant/grant.8388914
134 schema:sdDatePublished 2022-11-24T21:22
135 schema:sdLicense https://scigraph.springernature.com/explorer/license/
136 schema:sdPublisher N5269ad1069254d6486d64aabb72a6402
137 schema:startDate 2019-03-15
138 schema:url http://projectreporter.nih.gov/project_info_description.cfm?aid=10366094
139 sgo:license sg:explorer/license/
140 sgo:sdDataset grants
141 rdf:type schema:MonetaryGrant
142 N31ce99adc23f4abe8465eb0e95354704 schema:name nih_id
143 schema:value R01HL147355
144 rdf:type schema:PropertyValue
145 N462e16d6c0034f27bd45116416685bae schema:currency USD
146 schema:value 1762727.0
147 rdf:type schema:MonetaryAmount
148 N5269ad1069254d6486d64aabb72a6402 schema:name Springer Nature - SN SciGraph project
149 rdf:type schema:Organization
150 N94f0c214f12f4a1a8babe4c87b6d4415 schema:name dimensions_id
151 schema:value grant.8388914
152 rdf:type schema:PropertyValue
153 Ndbc359a766b948d6881faee678ac3dfc schema:member sg:person.01136172260.58
154 schema:roleName PI
155 rdf:type schema:Role
156 anzsrc-for:40 schema:inDefinedTermSet anzsrc-for:
157 rdf:type schema:DefinedTerm
158 sg:person.01136172260.58 schema:affiliation grid-institutes:None
159 schema:familyName FAN
160 schema:givenName ZHAOYANG
161 rdf:type schema:Person
162 grid-institutes:None schema:name UNIVERSITY OF SOUTHERN CALIFORNIA
163 rdf:type schema:Organization
164 grid-institutes:grid.279885.9 schema:Organization
165 grid-institutes:grid.42505.36 schema:Organization
 




Preview window. Press ESC to close (or click here)


...